The measurement and correlation analysis of scleral and choroid thickness in branch retinal vein occlusion.
Branch retinal vein occlusion
Choroid thickness
Scleral thickness
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 06 2024
23 06 2024
Historique:
received:
17
03
2024
accepted:
17
06
2024
medline:
24
6
2024
pubmed:
24
6
2024
entrez:
23
6
2024
Statut:
epublish
Résumé
To use Optical Coherence Tomography (OCT) to measure scleral thickness (ST) and subfoveal choroid thickness (SFCT) in patients with Branch Retinal Vein Occlusion (BRVO) and to conduct a correlation analysis. A cross-sectional study was conducted. From May 2022 to December 2022, a total of 34 cases (68 eyes) of untreated unilateral Branch Retinal Vein Occlusion (BRVO) patients were recruited at the Affiliated Eye Hospital of Nanchang University. Among these cases, 31 were temporal branch vein occlusions, 2 were nasal branch occlusions, and 1 was a superior branch occlusion. Additionally, 39 cases (39 eyes) of gender- and age-matched control eyes were included in the study. Anterior Segment Optical Coherence Tomography (AS-OCT) was used to measure ST at 6 mm superior, inferior, nasal, and temporal to the limbus, while Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT) was used to measure SFCT. The differences in ST and SFCT between the affected eye, contralateral eye, and control eye of BRVO patients were compared and analyzed for correlation. The axial lengths of the BRVO-affected eye, contralateral eye, and control group were (22.92 ± 0.30) mm, (22.89 ± 0.32) mm and (22.90 ± 0.28) mm respectively, with no significant difference in axial length between the affected eye and contralateral eye (P > 0.05). The SFCT and ST measurements in different areas showed significant differences between the BRVO-affected eye, contralateral eye in BRVO patients (P < 0.05). The CRT of BRVO-affected eyes was significantly higher than that of the contralateral eyes and the control eyes (P < 0.001). In comparison between BRVO-affected eyes and control eyes, there were no statistically significant differences in age and axial length between the two groups (P > 0.05). However, significant differences were observed in SFCT and temporal, nasal, superior, and inferior ST between the two groups (P < 0.05). The difference in temporal ST between the contralateral eyes and the control eyes was not statistically significant (t = - 0.35, P = 0.73). However, the contralateral group showed statistically significant increases in SFCT, nasal, superior and inferior ST compared to control eyes (t = - 3.153, 3.27, 4.21, 4.79, P = 0.002, 0.002, < 0.001, < 0.001). However, the difference between the CRT of the contralateral and control eyes was not statistically significant (P = 0.421). When comparing SFCT and ST between BRVO-affected eyes with and without macular edema, no statistically significant differences were found (t = - 1.10, 0.45, - 1.30, - 0.30, 1.00; P = 0.28, 0.66, 0.21, 0.77, 0.33). The thickness of SFCT and temporal ST in major BRVO group is higher than the macular BRVO group and the difference was statistically significant (t = 6.39, 7.17, P < 0.001 for all). Pearson correlation analysis revealed that in BRVO patients, there was a significant positive correlation between SFCT/CRT and temporal ST (r = 0.288, 0.355, P = 0.049, 0.04). However, there was no correlation between SFCT/CRT and nasal ST, superior ST, and inferior ST (P > 0.05). In BRVO patients, both SFCT/CRT and ST increase, and there is a significant correlation between SFCT/CRT and the ST at the site of vascular occlusion.
Identifiants
pubmed: 38910147
doi: 10.1038/s41598-024-65111-3
pii: 10.1038/s41598-024-65111-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
14440Subventions
Organisme : National Natural Science Foundation of China
ID : 82260212
Organisme : Key Research and Development Program of Science and Technology Department of Jiangxi Province-Key Projects (Unveiled)
ID : 20223BBH80W01
Organisme : cience and Technology Program of Health Commission of Jiangxi Province
ID : 202410040
Organisme : Key Project of Education Department of Jiangxi Province
ID : GJJ210126
Organisme : Key Project of Jiangxi Natural Science Foundation
ID : 20232ACB206029
Organisme : Central Government Guided Local Science and Technology Development Fund
ID : 2022ZDG02012
Organisme : Key Project of Science and Technology Innovation of Health Commission of Jiangxi Province
ID : 2023ZD004
Informations de copyright
© 2024. The Author(s).
Références
Nicholson, L. et al. Retinal vein occlusion (RVO) guideline: executive summary [J]. Eye (Lond) 1, 1 (2022).
Song, P. et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors [J]. J. Glob. Health 9(1), 10427 (2019).
doi: 10.7189/jogh.09.010427
Rehak, J. & Rehak, M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities [J]. Curr. Eye Res. 33(2), 111–131 (2008).
doi: 10.1080/02713680701851902
pubmed: 18293182
pmcid: 2430176
Aribas, Y. K., Hondur, A. M. & Tezel, T. H. Choroidal vascularity index and choriocapillary changes in retinal vein occlusions [J]. Graefes Arch. Clin. Exp. Ophthalmol. 258(11), 2389–2397 (2020).
doi: 10.1007/s00417-020-04886-3
pubmed: 32860575
Chen, L. et al. Choroidal thickening in retinal vein occlusion patients with serous retinal detachment [J]. Graefes Arch. Clin. Exp. Ophthalmol. 259(4), 883–889 (2021).
doi: 10.1007/s00417-020-04983-3
pubmed: 33205242
Sakanishi, Y. et al. Relationship between recurrence of macular edema due to branch retinal vein occlusion and changes in choroidal thickness [J]. Ophthal. Res. 64(3), 363–368 (2021).
doi: 10.1159/000512357
Tang, F. et al. Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO [J]. BMC Ophthalmol. 19(1), 133 (2019).
doi: 10.1186/s12886-019-1143-9
pubmed: 31226968
pmcid: 6588881
Alis, A. & Guler, A. M. The effect of branch retinal vein occlusion on the vascular structure of the choroid [J]. Photodiagn. Photodyn. Ther. 37, 102687 (2022).
doi: 10.1016/j.pdpdt.2021.102687
Wang, Q. et al. Optical coherence tomography angiography in retinal vein occlusions [J]. Graefe’s Arch. Clin. Exp. Ophthalmol. 256(9), 1615–1622 (2018).
doi: 10.1007/s00417-018-4038-1
Keidel, L. F. et al. Pachychoroid disease and its association with retinal vein occlusion: a case-control study [J]. Sci. Rep. 11(1), 19854 (2021).
doi: 10.1038/s41598-021-99115-0
pubmed: 34615888
pmcid: 8494827
Venkatesh, P., Takkar, B. & Temkar, S. Clinical manifestations of pachychoroid may be secondary to pachysclera and increased scleral rigidity [J]. Med. Hypotheses 113, 72–73 (2018).
doi: 10.1016/j.mehy.2018.02.024
pubmed: 29523299
Suzuki, H. et al. Changes in conjunctival-scleral thickness after strabismus surgery measured with anterior segment optical coherence tomography [J]. Jpn J. Ophthalmol. 62(5), 554–559 (2018).
doi: 10.1007/s10384-018-0609-2
pubmed: 29980870
Read, S. A. et al. Anterior eye tissue morphology: Scleral and conjunctival thickness in children and young adults [J]. Sci. Rep. 6(1), 1 (2016).
doi: 10.1038/srep33796
Woodman-Pieterse, E. C. et al. Anterior scleral thickness changes with accommodation in myopes and emmetropes [J]. Exp. Eye Res. 177, 96–103 (2018).
doi: 10.1016/j.exer.2018.07.023
pubmed: 30040950
Imanaga, N. et al. Scleral thickness in central serous chorioretinopathy [J]. Ophthalmol. Retina 5(3), 285–291 (2021).
doi: 10.1016/j.oret.2020.07.011
pubmed: 32683110
Li, J. Q. et al. Prevalence of retinal vein occlusion in Europe: A systematic review and meta-analysis [J]. Ophthalmologica 241(4), 183–189 (2019).
doi: 10.1159/000494224
pubmed: 30517942
Alis, A. & Guler, A. M. The effect of branch retinal vein occlusion on the vascular structure of the choroid [J]. Photodiagn. Photodyn. Ther. 37, 102687 (2022).
doi: 10.1016/j.pdpdt.2021.102687
Moleiro, A. F. et al. Peripapillary and subfoveal choroidal thickness in retinal vein occlusions [J]. Clin. Ophthalmol. 16, 3775–3783 (2022).
doi: 10.2147/OPTH.S379373
pubmed: 36415602
pmcid: 9675997
Yan, F. et al. The influence of the choroidal thickness of the affected eye about anti-vascular endothelial growth factor drug treatment for retinal vein occlusion with macular edema [J]. Chin. J. Ocul. Fund. Dis. 37(9), 681–686 (2021).
Gallice, M. et al. Hypoxic, Hypercapnic, and hyperoxic responses of the optic nerve head and subfoveal choroid blood flow in healthy humans [J]. Invest. Ophthalmol. Vis. Sci. 58(12), 5460–5467 (2017).
doi: 10.1167/iovs.17-21855
pubmed: 29059313
Hui, Y. N. Peripapillary pachychoroid syndrome: A novel entity of pachychoroid disease spectrum [J]. Int. Eye Sci. 23(01), 1–3 (2023).
Mitamura, Y. et al. Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion [J]. Br. J. Ophthalmol. 105(5), 704–710 (2021).
doi: 10.1136/bjophthalmol-2020-316214
pubmed: 32620686
Chung, Y., Shin, J. & Park, Y. Choroidal volume in branch retinal vein occlusion before and after intravitreal anti-VEGF injection [J]. Retina 35(6), 1234–1239 (2015).
doi: 10.1097/IAE.0000000000000455
pubmed: 25574783
Adiyeke, S. K. et al. Thicknesses of sclera and lamina cribrosa in patients with central retinal vein occlusion [J]. Retina 40(10), 2050–2054 (2020).
doi: 10.1097/IAE.0000000000002712
pubmed: 31834133
Dongyang, R. Quantitative OCTA study of the optic disc region of the contralateral eye in patients with unilateral retinal vein occlusion [D] (Nanchang University, 2022).
Zhu, S. J. et al. Quantitative analysis of the changes of optic disc in patients with monocular retinal vein occlusion [J]. Int. Eye Sci. 23(1), 158–162 (2023).